PharmaCyte Biotech, Inc.PMCBNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank93
Year-over-Year Change
Price-to-earnings ratio
Latest
0.30
↑ 113% vs avg
Percentile
P93
Near historical high
Streak
1 yr
Consecutive declineElevated
Average
-2.33
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.30 | -99.5% |
| 2024 | 60.86 | +561.5% |
| 2023 | -13.19 | -54.5% |
| 2022 | -8.53 | +23.7% |
| 2021 | -11.18 | -24.6% |
| 2020 | -8.97 | +21.8% |
| 2019 | -11.46 | -44.8% |
| 2018 | -7.91 | +45.1% |
| 2017 | -14.43 | -64.3% |
| 2016 | -8.78 | - |